
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Syringe labels are essential for hospitals and pharmacies because they reduce the possibility of giving patients the incorrect drugs or prescriptions. To expeditiously administer a drug to a patient and guarantee proper dosage, medications are frequently pre-loaded into syringes.
The availability of injectable medications, however, also raises the danger of improper administration. Even though health professionals are trained to handle these things properly, a few situations have happened as a result of incorrect labelling or a lack of identification.
The improper medication or dose can easily be administered using an unlabeled syringe. Furthermore, any unmarked item containing a medication or anaesthesia will frequently pass through multiple hands.
The writing on the identification could smear or deteriorate throughout this transit. Other times, it might not be labelled, making it challenging to locate the medication once it gets there.
Another illustration would be filling a syringe with medication and leaving it in a location where saline flushes are kept. This could lead to the IV unintentionally being flushed with a medication instead of saline.
TheGlobal Syringe Labels marketaccounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
For its syringe product line of compounded sterile products (CSPs), QuVa Pharma, Inc. stated that it has introduced a new flag label design for which it has applied for a design patent.
These updated labels were created by QuVa Pharma in collaboration with its clients, and the company has started to change the labels on all of its needles.
A quality improvement targeted at lowering medication and dosing errors is the delivery of an improved syringe label with complete drug and dosing visibility, regardless of syringe orientation.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |